Henry Schein to repurchase $400M in shares

Henry Schein, a dental supplier company, will repurchase up to $400 million of its common stock.

The repurchase plan is in addition to a separate $400 million repurchasing program the company began in August 2022, which is expected to be completed by the end of the first quarter, according to a Feb. 13 news release. 

The $400 million authorization will allow the company to buy back about 3.8 percent of its more than 131 million outstanding shares at the current stock price. 

The stock purchases will be occasionally made on the open market and through negotiated transactions, the release said.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.